If you have heard of Ozempic, you have probably heard about it from a celebrity headline or a viral social media post rather than your doctor. The product has become a cultural moment over the last few years, particularly in the United States, and the interest has carried over into South Africa.
This guide explains what the product actually is, how it is available in South Africa, and how to think about it sensibly in the context of weight loss treatment.
What it is and what it does
The product is a brand name for semaglutide, a synthetic version of the GLP-1 hormone. It is manufactured by Novo Nordisk, a Danish pharmaceutical company, and was originally developed and approved for the treatment of type 2 diabetes. It works by activating GLP-1 receptors in the body, which improves blood sugar regulation, slows gastric emptying, and reduces appetite.
The weight loss effects became apparent during the diabetes trials, and have since been studied extensively in their own right. The same active ingredient is sold under a different brand name with a higher dose specifically for weight management. For weight loss purposes, the two products work identically. The branding and dose strength are what differ.
Availability in South Africa
The diabetes version of the product has been approved and available in South Africa for several years. It is a Schedule 4 medication, meaning it requires a prescription from a registered medical practitioner and is dispensed only at licensed pharmacies.
Availability has been intermittent over the last two years because global demand outstripped manufacturing capacity. South African pharmacies have experienced periodic stockouts, particularly of certain dose strengths. The situation has improved through 2025 and into 2026 as the manufacturer has expanded production, though some doses remain harder to source than others.
The dedicated weight loss formulation, with the higher dose strengths, has had a slower introduction to the South African market and remains less widely available than the diabetes version. Many South African patients prescribed GLP-1 therapy for weight loss are using off-label scripts of the diabetes formulation, which is clinically equivalent at the appropriate dose.
Use for weight loss
For weight management, the medication is prescribed to adults meeting specific clinical criteria: a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, prediabetes, raised cholesterol, fatty liver, or sleep apnoea.
The clinical evidence for weight loss is substantial. In the largest published trial, average weight loss over 68 weeks was around 15 percent of starting body weight, compared to 2.4 percent in patients receiving placebo. For someone starting at 100 kg, that translates to roughly 15 kg of loss over a year and a quarter.
The mechanism is the same as other GLP-1 therapies. The medication reduces appetite, slows gastric emptying so meals feel filling for longer, and reduces what patients commonly describe as food noise. The result is that eating less feels natural rather than forced, which is what makes the loss sustainable in a way that diet alone usually is not.
Side effects are generally mild and time-limited. Nausea is the most common, particularly during dose escalation. Constipation, mild stomach discomfort, and occasional fatigue are also reported. Most patients find the side effects entirely manageable, and they tend to settle within a few weeks of starting or after each dose increase.
Cost in South Africa
Pricing varies significantly by pharmacy and by dose. At the time of writing, monthly costs for the diabetes formulation at standard South African pharmacies range from around R2,000 at the lowest dose to over R4,000 at the higher therapeutic doses. The dedicated weight loss formulation, where available, is generally priced similarly.
Most South African medical aids do not currently cover GLP-1 therapy for weight management, though coverage is expanding for diabetes patients meeting specific clinical criteria. Bloodwork associated with monitoring during treatment is usually claimable from medical savings even where the medication is not.
For a more detailed breakdown of total programme costs in South Africa, including consultation fees, monitoring, and how to budget realistically, see our complete cost guide.
How to access it legally
The medication is prescription-only in South Africa. Anyone selling it without a prescription, or distributing it through informal channels, is operating illegally and the product cannot be guaranteed to be authentic.
The legitimate path is a consultation with a registered medical practitioner who will assess your eligibility, review your medical history, and prescribe if appropriate. This can happen through your existing GP, through a specialist physician or endocrinologist, or through a registered telemedicine service offering online consultations.
Counterfeit products have appeared globally and in South Africa. These range from inert substances priced as genuine medication to actively dangerous formulations containing unverified ingredients. The savings from buying through unofficial channels are not worth the risk to your health.
Only purchase GLP-1 medications from licensed pharmacies on the basis of a prescription from a registered doctor. Compounded versions, online imports, and informal market sources have all been associated with safety incidents in 2024 and 2025.
The wider GLP-1 picture
The product is one of several GLP-1 medications available globally, and the number of options in South Africa is expanding. The decision about which specific medication is appropriate for you should rest with your prescribing doctor, who will consider your medical history, dose response, and the practical availability at the time of prescribing.
For most patients, the specific brand matters less than the broader treatment approach. What matters is:
- Whether GLP-1 therapy is clinically appropriate for your situation, based on BMI and any weight-related conditions
- Whether you have a doctor who has reviewed your bloodwork and history before prescribing
- Whether you have ongoing support to manage side effects and adjust dose
- Whether you are building the habits that will sustain weight loss after the medication ends
A good clinical programme provides all four. A script-only service provides only the first, and at higher long-term cost when complications appear.
Find out if GLP-1 therapy is appropriate for you.
A three minute eligibility check, followed by a proper doctor consultation if you qualify. We do not name specific brands in our consultations, but we prescribe whichever clinically appropriate GLP-1 medication is available and suited to your situation.
Check EligibilityThe bottom line
The product is one specific brand of GLP-1 therapy, available in South Africa under prescription. It works the same way as other GLP-1 medications and produces broadly similar outcomes. The clinical decision about which specific product to prescribe for your situation is your doctor's, not a marketing choice.
If you are considering GLP-1 therapy, the right starting point is an honest eligibility check and a proper consultation, not chasing a specific brand name. The framework matters more than the label.